For research use only. Not for therapeutic Use.
Imatinib Impurity E（Cat No.:R058411）is a process-related byproduct associated with the synthesis of imatinib, a tyrosine kinase inhibitor widely used in chronic myeloid leukemia and gastrointestinal stromal tumor research. As an impurity reference standard, it plays a critical role in pharmaceutical quality control, stability studies, and analytical method validation. Researchers utilize Imatinib Impurity E to investigate degradation pathways, ensure product safety, and maintain regulatory compliance in drug development. Its defined structure and characterization support accurate impurity profiling, making it an essential tool in analytical and medicinal chemistry research.
| CAS Number | 1365802-18-1 |
| Synonyms | N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[[4-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]piperazin-1-yl]methyl]benzamide |
| Molecular Formula | C52H48N12O2 |
| Purity | ≥95% |
| IUPAC Name | N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-[[4-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]piperazin-1-yl]methyl]benzamide |
| InChI | InChI=1S/C52H48N12O2/c1-35-7-17-43(29-47(35)61-51-55-23-19-45(59-51)41-5-3-21-53-31-41)57-49(65)39-13-9-37(10-14-39)33-63-25-27-64(28-26-63)34-38-11-15-40(16-12-38)50(66)58-44-18-8-36(2)48(30-44)62-52-56-24-20-46(60-52)42-6-4-22-54-32-42/h3-24,29-32H,25-28,33-34H2,1-2H3,(H,57,65)(H,58,66)(H,55,59,61)(H,56,60,62) |
| InChIKey | DZHKYOWYCVBDPW-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)CC4=CC=C(C=C4)C(=O)NC5=CC(=C(C=C5)C)NC6=NC=CC(=N6)C7=CN=CC=C7)NC8=NC=CC(=N8)C9=CN=CC=C9 |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
